Document is current
Any future updates will be listed below
-
Authors
Khanna, Vishesh https://orcid.org/0000-0001-8930-7401
Eslami, Gohar
Reyes, Rochelle
Diep, Robert
Fernandez-Pol, Sebastian
Stehr, Henning
Suarez, Carlos Jose
Pinto, Harlan
Ford, James M. https://orcid.org/0000-0002-2513-7025
Zhang, Tian Yi
Chen, Christopher T.
- License Information
-
More Information
Article History
Received: 15 July 2024
Accepted: 24 January 2025
First Online: 3 February 2025
Competing interests
: C.C. has received research grants (to his institution) from the following: Cholangiocarcinoma Foundation, ADC Therapeutics, Oric Pharmaceuticals, Seattle Genetics, Rain Therapeutics, Kinnate, Gilead, Mersana Therapeutics, Riboscience, Takeda, Palleon, Merus, Revolution Medicines, Tango Therapeutics, and Genentech-Roche, and has received consulting fees from Boxer Capital and Guidepoint Global Advisors. The remaining authors report no competing interests.
